DUBLIN, March 10, 2022–(BUSINESS WIRE)–The “2021-2025 Nicergoline Chinese Market Survey Report” report has been added to from ResearchAndMarkets.com offer.
Nicergoline is a kind of ergot derivative, used to treat Alzheimer’s disease and other vascular diseases, originally researched by Pfizer Pharmaceuticals.
Since its successful development in the 1960s, it has been registered and used in over 50 countries. In 2020, Nicergoline was included in China’s Class B medical insurance, and there are already several manufacturers in the Chinese market, including Kunshan Longdeng Ruidi Pharmaceutical Co., Ltd. holds the largest market share.
According to the analyst’s market research, the sales value of Nicergoline in the Chinese market increased year by year from 2016 to 2020. Among them, the growth in 2019 was the most obvious.
The sales value of Nicergoline increased from CNY 138 million in 2018 to CNY 190 million in 2019, with an annual growth rate of 37.57%. In 2020, the sales value of Nicergoline in the Chinese market is CNY 237 million, and the CAGR from 2016 to 2020 is 16.6%.
The analyst expects that with the increase in the number of Alzheimer’s disease patients, the sales value of Nicergoline in the Chinese market will continue to grow from 2021 to 2025.
In 2020, the incidence of Alzheimer’s disease among people over the age of 65 in China was 4-6%, and the degree of aging in China will continue to increase in the future, which will lead to the continuation of the number of patients with Alzheimer’s disease. to augment. Therefore, the sales volume and sales value of Nicergoline will also continue to increase.
The impact of COVID-19 on the Chinese Nicergoline market
Nicergoline sales value in China 2016-2020
Competitive Landscape of Chinese Nicergoline Market
Nicergoline Price in China
Nicergoline Price in China by Regions and Manufacturers
Analysis of factors affecting the development of the Chinese Nicergoline market
China Nicergoline Market Outlook from 2021 to 2025
Main topics covered:
1 Relevant Concepts of Nicergoline
1.1 Indications of Nicergoline
1.2 Nicergoline Development in China
1.3 Nicergoline Government Approval in China
1.4 The impact of COVID-19 on Nicergoline sales in China
2 China Nicergoline Sales, 2016-2020
2.1 Nicergoline Sales Value
2.1.1 Overall sales value
2.1.2 Sales Value by Region
2.2 Nicergoline Sales Volume
2.2.1 Overall Sales Volume
2.2.2 Sales Volume by Region
2.3 Nicergoline Sales by Dosage Form in China, 2016- 2020
3 Analysis of Nicergoline Key Manufacturers in China, 2016-2020
3.1 Nicergoline Key Manufacturers Market Share Analysis
3.1.1 Market Share Survey by Sales Value
3.1.2 Market Share Survey by Sales Volume
3.2 Kunshan Longdeng Ruidi Pharmaceutical Co., Ltd.
3.2.1 Company Profile
3.2.2 China Lexilin (Nicergoline by Kunshan Longdeng Ruidi Pharmaceutical Co., Ltd.) Sales
3.3 Hainan General Kangli Pharmaceutical Co., Ltd.
3.3.1 Company Profile
3.3.2 China Hainan Puli (Nicergoline from Hainan General Kangli Pharmaceutical Co., Ltd.) Sales
3.4 Pfizer Pharmaceuticals Co., Ltd.
3.4.1 Company Profile
3.4.2 China SERMION (Nicergoline by Pfizer Pharmaceuticals Co., Ltd.) Sales
3.5 Chengdu Tiantaishan Pharmaceutical Co., Ltd.
3.5.1 Business Profile
3.5.2 China Fulutong (Nicergoline by Chengdu Tiantaishan Pharmaceutical Co., Ltd.) Sales
3.6 Hainan General Sanyo Pharmaceutical Co., Ltd.
3.6.1 Company Profile
3.6.2 Kaier (Nicergoline from Hainan general Sanyo Pharmaceutical Co., Ltd.) Sales in China
4 Nicergoline Prices for Different Manufacturers in China, 2020-2021
4.1 Kunshan Longdeng Ruidi Pharmaceutical Co., Ltd. (Lexiline)
4.2 Hainan General Kangli Pharmaceutical Co., Ltd. (Hainan Puli)
4.3 Pfizer Pharmaceuticals Co., Ltd. (SERMION)
4.4 Chengdu Tiantaishan Pharmaceutical Co., Ltd. (Fulutong)
4.5 Hainan General Sanyo Pharmaceutical Co., Ltd. (Kaier)
5 China Nicergoline Market Outlook, 2021-2025
5.1 Influencing Factors of China Nicergoline Market Development
5.1.1 The impact of COVID-19 on the Chinese Nicergoline market
5.1.2 Market Drivers and Opportunities
5.1.3 Market Threats and Challenges
5.2 Market Size Forecast
5.3 Market Trend Forecast
For more information on this report, visit https://www.researchandmarkets.com/r/38mdso
See the source version on businesswire.com: https://www.businesswire.com/news/home/20220310005697/en/
Laura Wood, Senior Press Officer
For EST business hours, call 1-917-300-0470
For US/CAN call toll free 1-800-526-8630
For GMT office hours call +353-1-416-8900